Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Targeted Search
Clinical Trials Search Results
Search History:
Count: 2378
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06989086 | FearLess in NeuroOncology | ||
| NCT03526822 | Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features. | ||
| NCT00535379 | SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme | ||
| NCT03251027 | Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma | ||
| NCT01095094 | Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma | ||
| NCT05798273 | (68^Ga)-GaPSMA-11 PET/MR-imaging of Malignant Intra-axial Brain Tumors | ||
| NCT05476341 | A Phase I Clinical Trial of Bevacizumab Injection | ||
| NCT05563272 | 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors | ||
| NCT00002619 | Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors | ||
| NCT05171127 | Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument | ||
| NCT01281982 | (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas | ||
| NCT00498927 | Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma | ||
| NCT01209442 | Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme | ||
| NCT04715620 | Niraparib Combined With Radiotherapy in rGBM | ||
| NCT00276783 | Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases | ||
| NCT06860594 | Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma | ||
| NCT01269853 | Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA | ||
| NCT06160596 | Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis | ||
| NCT04439331 | Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U) | ||
| NCT01011231 | Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma | ||
| NCT00597402 | Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas | ||
| NCT00002753 | Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas | ||
| NCT05120960 | A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors | ||
| NCT06336291 | A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence | ||
| NCT00498979 | Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers | ||
| NCT05902169 | Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM | ||
| NCT00940498 | Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors | ||
| NCT07472387 | Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas | ||
| NCT00049387 | Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma | ||
| NCT03452579 | Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM | ||
| NCT04802447 | SurVaxM Expanded Access Protocol | ||
| NCT04365647 | Intra-operative Variation in Size of Brain Tumors After Craniotomy | ||
| NCT03567135 | Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma | ||
| NCT04671459 | TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine | ||
| NCT00087061 | Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma | ||
| NCT00098761 | VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors | ||
| NCT00003241 | Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors | ||
| NCT05086497 | WBSI Guided Personalized Delivery of TTFields | ||
| NCT00650923 | Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma | ||
| NCT02345824 | Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma | ||
| NCT04222309 | Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) | ||
| NCT01861990 | Valproic Acid in Childhood Progressive Brain Tumors | ||
| NCT04657146 | Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma | ||
| NCT00238303 | Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme | ||
| NCT06360588 | Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G) | ||
| NCT04933942 | Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma | ||
| NCT05977322 | A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors. | ||
| NCT00433472 | MRI in Evaluating the Effect of Efaproxiral on the Brain in Patients With Recurrent or Progressive Glioma Enrolled on Clinical Trial NABTT-9806 | ||
| NCT01854099 | Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens | ||
| NCT06975332 | Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression |
